Application 206294
- Type
- ANDA
- Sponsor
- PAR PHARM INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ENTECAVIR | ENTECAVIR | TABLET;ORAL | 0.5MG | No | No |
| 002 | ENTECAVIR | ENTECAVIR | TABLET;ORAL | 1MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206294-001 | ENTECAVIR | ENTECAVIR | 0.5MG | TABLET / ORAL | 2016-11-23 | ||
| A206294-002 | ENTECAVIR | ENTECAVIR | 1MG | TABLET / ORAL | 2016-11-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A206294-001 | ENTECAVIR | 0.5MG | TABLET / ORAL | 2016-11-23 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A206294-002 | ENTECAVIR | 1MG | TABLET / ORAL | 2016-11-23 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A206294-001 | ENTECAVIR | 0.5MG | TABLET / ORAL | 2016-11-23 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A206294-002 | ENTECAVIR | 1MG | TABLET / ORAL | 2016-11-23 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A206294-001 | ENTECAVIR | 0.5MG | TABLET / ORAL | 2016-11-23 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A206294-002 | ENTECAVIR | 1MG | TABLET / ORAL | 2016-11-23 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A206294-001 | ENTECAVIR | 0.5MG | TABLET / ORAL | 2016-11-23 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A206294-002 | ENTECAVIR | 1MG | TABLET / ORAL | 2016-11-23 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206294-001 | ENTECAVIR | 0.5MG | TABLET / ORAL | 2016-11-23 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206294-002 | ENTECAVIR | 1MG | TABLET / ORAL | 2016-11-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A206294-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A206294-002 | AB | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | A206294-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A206294-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A206294-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A206294-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Entecavir | ENTECAVIR | Aurobindo Pharma Limited | def332bf-2906-4a6c-b85d-dfb56bb94312 | 2026-11-10 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| ENTECAVIR | ENTECAVIR | NorthStar RxLLC | da705339-c349-444f-a058-4f0cef2864bf | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | ENTECAVIR ENTECAVIR |
| ENTECAVIR | ENTECAVIR | Cipla USA Inc. | d59e9ea4-09ea-47bd-af2f-39f7a2e2aceb | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | ENTECAVIR ENTECAVIR |
| ENTECAVIR | ENTECAVIR | Yaopharma Co., Ltd. | 73dea2a4-a596-477f-b66d-5a80dd019837 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | ENTECAVIR ENTECAVIR |
| Entecavir | ENTECAVIR | AvKARE | 5a1cbf7e-0352-aa3b-080c-222a6423ecd8 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| Entecavir | ENTECAVIR | Golden State Medical Supply, Inc. | 20d62f1a-2e48-69dd-e063-6294a90ace31 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| Entecavir | ENTECAVIR | Epic Pharma, LLC | d69451df-e204-4a5c-a2bb-9e6d4d519302 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| Entecavir | ENTECAVIR | EPIC PHARMA, LLC | af4f47e2-f556-40f2-a0fd-ff81e9f27429 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| Entecavir | ENTECAVIR | Carlsbad Technology, Inc. | 1a905283-0057-a7dd-e063-6394a90a1909 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| ENTECAVIR | ENTECAVIR ANHYDROUS | Cameron Pharmaceuticals | 92a5bebd-6408-463d-933c-bab8338a677e | 2025-06-05 | Boxed warning, Warnings, Adverse reactions | ENTECAVIR |
| Entecavir | ENTECAVIR | Camber Pharmaceuticals, Inc. | 01ec50a1-6c6c-46f0-8c74-73542b0a59c3 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| Entecavir | ENTECAVIR | Zydus Lifesciences Limited | 0e3b2a0a-9076-4907-bbaf-eb6a65bb9481 | 2024-11-28 | Entecavir ENTECAVIR | |
| ENTECAVIR | ENTECAVIR | Solco Healthcare LLC | bb1bb6dc-0120-46e2-ad1e-d9afc221fa16 | 2024-11-20 | Boxed warning, Warnings, Adverse reactions | ENTECAVIR ENTECAVIR |
| Entecavir | ENTECAVIR | American Health Packaging | a0d2e00d-21f0-4449-93b7-a19fa284d51d | 2024-08-15 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| Entecavir | ENTECAVIR | Zydus Pharmaceuticals USA Inc. | b4fd0e22-ad23-4f51-9b98-95182f63c2eb | 2023-10-05 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| Entecavir | ENTECAVIR | Amneal Pharmaceuticals LLC | 007a6ad8-4d23-4543-ae48-c651cac7dd7b | 2019-11-24 | Boxed warning, Warnings, Adverse reactions | Entecavir ENTECAVIR |
| BARACLUDE | ENTECAVIR | E.R. Squibb & Sons, L.L.C. | 046e61c9-9298-4b2e-b76e-b26b81fecd20 | 2019-11-06 | Boxed warning, Warnings, Adverse reactions | ENTECAVIR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 49884-547 | Entecavir | Entecavir | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-547 | Entecavir | Entecavir | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-548 | Entecavir | Entecavir | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-548 | Entecavir | Entecavir | Par Pharmaceutical, Inc. | ANDA | Current |